Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Austin K. Rennels"'
Autor:
Nils Wellhausen, Austin K Rennels, Stefanie Lesch, Sangya Agarwal, Brooke Charria, Grace Choi, Regina M Young, Christopher Garcia, Carl H June, Saar Gill
Publikováno v:
Blood. 140:862-864
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2c2520b3c9b77b7ac51dd5636b07bbd
https://doi.org/10.1182/blood-2022-158684
https://doi.org/10.1182/blood-2022-158684
Autor:
M. Angela Aznar, Charly R. Good, Shunichiro Kuramitsu, Parisa Samareh, Sangya Agarwal, Greg Donahue, Kenichi Ishiyama, Nils Wellhausen, Austin K. Rennels, Yujie Ma, Lifeng Tian, Sonia Guedan, Katherine A. Alexander, Zhen Zhang, Philipp C. Rommel, Nathan Singh, Karl M. Glastad, Max W. Richardson, Keisuke Watanabe, Janos L. Tanyi, Mark H. O’Hara, Marco Ruella, Simon F. Lacey, Edmund K. Moon, Stephen J. Schuster, Steven M. Albelda, Lewis L. Lanier, Regina M. Young, Shelley L. Berger, Carl H. June
Publikováno v:
Cancer Research. 82:3602-3602
Chimeric antigen receptor (CAR) T cell immunotherapy is FDA approved for the treatment of a subset of B cell malignancies but has shown limited clinical success in solid tumor therapy. T cell exhaustion is an important factor involved in treatment fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1139f5b8839d87d9d1b304b86a68bc2c
https://doi.org/10.1158/1538-7445.am2022-3602
https://doi.org/10.1158/1538-7445.am2022-3602
Autor:
Keisuke Watanabe, Charly R. Good, Kenichi Ishiyama, Greg Donahue, Marco Ruella, Lewis L. Lanier, Simon F. Lacey, Nathan Singh, Janos L. Tanyi, Austin K. Rennels, Shunichiro Kuramitsu, Yujie Ma, Lifeng Tian, Shelley L. Berger, Karl M. Glastad, Mark H. O'Hara, Regina M. Young, Parisa Samareh, Zhen Zhang, Edmund K. Moon, Carl H. June, M. Angela Aznar, Philipp C. Rommel, Steven M. Albelda, Katherine A. Alexander, Sangya Agarwal, Stephen J. Schuster, Max W. Richardson, Nils Wellhausen, Sonia Guedan
Publikováno v:
Cell
Summary Chimeric antigen receptor (CAR) T cell therapy has achieved remarkable success in hematological malignancies but remains ineffective in solid tumors, due in part to CAR T cell exhaustion in the solid tumor microenvironment. To study dysfuncti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db4dca3ac6b77cf3d1f795ac3d3904cd
https://pubmed.ncbi.nlm.nih.gov/34890549
https://pubmed.ncbi.nlm.nih.gov/34890549